article thumbnail

STAT+: ‘Skinny labels’ on generic medicines saved Medicare $15 billion over a recent six-year period

STAT

A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that period, according to a new analysis.

Labelling 109
article thumbnail

Sinking prices for generic meds a major factor in US shortage crisis: report

Fierce Pharma

drug shortages, a new white paper from German market analytics firm QYOBO supports the thesis that disproportionately low prices for generic medicines can make it difficult for drugmakers to keep supplies afloat. . | As lawmakers and industry groups seek to get a handle on U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FTC targets middlemen in generic drug shortages probe

pharmaphorum

The FTC is investigating wholesalers and other middlemen in the pharma supply chain to assess their possible role in worsening shortages of generic medicines

article thumbnail

STAT+: Drugmakers rely on ‘use codes’ to vastly expand the nature of their patent claims, STAT analysis shows

STAT

patent system by the pharmaceutical industry, moves by some drugmakers to expand their patent claims appear to be delaying the arrival of lower-cost generic medicines to the marketplace, according to a STAT analysis.  Amid debate over potential abuse of the U.S.

article thumbnail

Amazon extends $5 generic subscription service to Medicare

pharmaphorum

Amazon Pharmacy is expanding its subscription service for generic medicines, making it available to Medicare patients

article thumbnail

STAT+: FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of key documents

STAT

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration.

article thumbnail

Opinion: I went on a mind-boggling journey to get my son’s ADHD medication covered by insurance — twice

STAT

As a former editor for diabetes publications, I knew that insurance companies regularly switched people from one brand of insulin to another, or from a name brand of insulin to a generic. However, I had used generic medicine for my blood pressure without a problem, so I hoped for the best with this switch.

Insurance 121